Class information for:
Level 1: ACARBOSE//ALPHA GLUCOSIDASE INHIBITOR//MIGLITOL

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
8357 1262 32.2 70%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
176 3       DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES 58057
1896 2             METFORMIN//ACARBOSE//REPAGLINIDE 5944
8357 1                   ACARBOSE//ALPHA GLUCOSIDASE INHIBITOR//MIGLITOL 1262

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ACARBOSE authKW 1828187 15% 41% 184
2 ALPHA GLUCOSIDASE INHIBITOR authKW 1301905 12% 34% 157
3 MIGLITOL authKW 903219 4% 67% 56
4 ALPHA GLUCOSIDASE authKW 687923 13% 17% 170
5 POSTPRANDIAL HYPERGLYCEMIA authKW 289330 4% 24% 50
6 VOGLIBOSE authKW 221176 2% 38% 24
7 ALPHA GLUCOSIDASE INHIBITION authKW 197441 3% 20% 40
8 HPLC HRMS SPE NMR authKW 178155 1% 82% 9
9 AMINOOLIGOSACCHARIDE authKW 145166 0% 100% 6
10 TOUCHI EXTRACT authKW 145166 0% 100% 6

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Endocrinology & Metabolism 4235 23% 0% 290
2 Food Science & Technology 2276 16% 0% 205
3 Pharmacology & Pharmacy 1520 22% 0% 278
4 Nutrition & Dietetics 1466 10% 0% 120
5 Chemistry, Medicinal 1216 10% 0% 124
6 Chemistry, Applied 1120 10% 0% 120
7 Integrative & Complementary Medicine 1057 4% 0% 46
8 Medicine, General & Internal 266 8% 0% 105
9 Medicine, Research & Experimental 155 5% 0% 67
10 Agriculture, Multidisciplinary 123 2% 0% 31

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 HIGASHISONOGI TEA BRANCH 72583 0% 100% 3
2 FOOD BIOCHEMKITA KU 61927 1% 32% 8
3 BIOL ENGN FOOD IND 48389 0% 100% 2
4 TIANJIN STATE CELLULAR MOL IMMUNOL 48389 0% 100% 2
5 HUA XI MED 46521 0% 38% 5
6 BEST CELLULAR NUTR 32258 0% 67% 2
7 GEN FOODS 32258 0% 67% 2
8 REQUIMTELAQV FARMACOGNOSIA 32258 0% 67% 2
9 PHYTOMED PHYTOPHARMACOL GRP 32250 0% 22% 6
10 MED FOOD DEV 26290 0% 22% 5

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 DIABETES RESEARCH AND CLINICAL PRACTICE 6550 3% 1% 38
2 JOURNAL OF FOOD BIOCHEMISTRY 4372 1% 1% 17
3 DIABETES NUTRITION & METABOLISM 3064 1% 1% 9
4 DIABETES CARE 3011 3% 0% 38
5 DIABETES OBESITY & METABOLISM 2786 1% 1% 16
6 METABOLISM-CLINICAL AND EXPERIMENTAL 2753 3% 0% 32
7 FOOD SCIENCE AND BIOTECHNOLOGY 2682 2% 1% 19
8 NUTRITION RESEARCH AND PRACTICE 1930 1% 1% 7
9 CLINICAL DRUG INVESTIGATION 1851 1% 1% 13
10 DIABETIC MEDICINE 1669 2% 0% 20

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 ACARBOSE 1828187 15% 41% 184 Search ACARBOSE Search ACARBOSE
2 ALPHA GLUCOSIDASE INHIBITOR 1301905 12% 34% 157 Search ALPHA+GLUCOSIDASE+INHIBITOR Search ALPHA+GLUCOSIDASE+INHIBITOR
3 MIGLITOL 903219 4% 67% 56 Search MIGLITOL Search MIGLITOL
4 ALPHA GLUCOSIDASE 687923 13% 17% 170 Search ALPHA+GLUCOSIDASE Search ALPHA+GLUCOSIDASE
5 POSTPRANDIAL HYPERGLYCEMIA 289330 4% 24% 50 Search POSTPRANDIAL+HYPERGLYCEMIA Search POSTPRANDIAL+HYPERGLYCEMIA
6 VOGLIBOSE 221176 2% 38% 24 Search VOGLIBOSE Search VOGLIBOSE
7 ALPHA GLUCOSIDASE INHIBITION 197441 3% 20% 40 Search ALPHA+GLUCOSIDASE+INHIBITION Search ALPHA+GLUCOSIDASE+INHIBITION
8 HPLC HRMS SPE NMR 178155 1% 82% 9 Search HPLC+HRMS+SPE+NMR Search HPLC+HRMS+SPE+NMR
9 AMINOOLIGOSACCHARIDE 145166 0% 100% 6 Search AMINOOLIGOSACCHARIDE Search AMINOOLIGOSACCHARIDE
10 TOUCHI EXTRACT 145166 0% 100% 6 Search TOUCHI+EXTRACT Search TOUCHI+EXTRACT

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 JOSHI, SR , STANDL, E , TONG, NW , SHAH, P , KALRA, S , RATHOD, R , (2015) THERAPEUTIC POTENTIAL OF ALPHA-GLUCOSIDASE INHIBITORS IN TYPE 2 DIABETES MELLITUS: AN EVIDENCE-BASED REVIEW.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 16. ISSUE 13. P. 1959 -1981 78 55% 9
2 VAN DE LAAR, FA , LUCASSEN, PLBJ , AKKERMANS, RP , VAN DE LISDONK, EH , RUTTEN, GEHM , VAN WEEL, C , (2005) ALPHA-GLUCOSIDASE INHIBITORS FOR TYPE 2 DIABETES MELLITUS (REVIEW) - ART. NO. CD003639.PUB2.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - 57 85% 63
3 VAN DE LAAR, FA , LUCASSEN, PL , AKKERMANS, RP , VAN DE LISDONK, FH , RUTTEN, GE , VAN WEEL, C , (2005) ALPHA-GLUCOSIDASE INHIBITORS FOR PATIENTS WITH TYPE 2 DIABETES - RESULTS FROM A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS.DIABETES CARE. VOL. 28. ISSUE 1. P. 154-163 43 91% 189
4 CAI, XL , HAN, XY , LUO, YY , JI, LN , (2013) COMPARISONS OF THE EFFICACY OF ALPHA GLUCOSIDASE INHIBITORS ON TYPE 2 DIABETES PATIENTS BETWEEN ASIAN AND CAUCASIAN.PLOS ONE. VOL. 8. ISSUE 11. P. - 50 78% 2
5 LAUBE, H , (2002) ACARBOSE - AN UPDATE OF ITS THERAPEUTIC USE IN DIABETES TREATMENT.CLINICAL DRUG INVESTIGATION. VOL. 22. ISSUE 3. P. 141 -156 57 85% 46
6 LEBOVITZ, HE , (1998) ALPHA-GLUCOSIDASE INHIBITORS AS AGENTS IN THE TREATMENT OF DIABETES.DIABETES REVIEWS. VOL. 6. ISSUE 2. P. 132-145 50 85% 120
7 SCHEEN, AJ , (1998) CLINICAL EFFICACY OF ACARBOSE IN DIABETES MELLITUS: A CRITICAL REVIEW OF CONTROLLED TRIALS.DIABETES & METABOLISM. VOL. 24. ISSUE 4. P. 311 -320 45 94% 42
8 SCHEEN, AJ , (2003) IS THERE A ROLE FOR ALPHA-GLUCOSIDASE INHIBITORS IN THE PREVENTION OF TYPE 2 DIABETES MELLITUS?.DRUGS. VOL. 63. ISSUE 10. P. 933 -951 57 59% 75
9 KUMAR, RV , SINHA, VR , (2012) NEWER INSIGHTS INTO THE DRUG DELIVERY APPROACHES OF ALPHA-GLUCOSIDASE INHIBITORS.EXPERT OPINION ON DRUG DELIVERY. VOL. 9. ISSUE 4. P. 403 -416 37 73% 5
10 BREUER, HWM , (2003) REVIEW OF ACARBOSE THERAPEUTIC STRATEGIES IN THE LONG-TERM TREATMENT AND IN THE PREVENTION OF TYPE 2 DIABETES.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 41. ISSUE 10. P. 421-440 57 55% 49

Classes with closest relation at Level 1



Rank Class id link
1 10965 GLYCEMIC VARIABILITY//GLYCAEMIC VARIABILITY//GLUCOSE VARIABILITY
2 33267 ATTA UR RAHMAN NAT PROD DISCOVERY//UCSS//COMPUTAT MED CHEM
3 16225 REPAGLINIDE//NATEGLINIDE//MITIGLINIDE
4 11103 ALPHA AMYLASE INHIBITOR//ARCELIN//AMYLASE INHIBITOR
5 27561 TELFAIRIA OCCIDENTALIS//FUNCT FOODS NUTRACEUT UNIT//FLUTED PUMPKIN
6 5136 MOMORDICA CHARANTIA//BITTER MELON//SYZYGIUM CUMINI
7 8850 METFORMIN//LACTIC ACIDOSIS//BIGUANIDES
8 36751 PARKIA SPECIOSA//TEMUAN//DILLENIA SUFFRUTICOSA
9 19115 INDIGENOUS PROCESSING METHODS//TOTAL FREE PHENOLICS//PROLINE LINKED PENTOSE PHOSPHATE PATHWAY
10 21661 ALPHA GLUCOSIDASE//OLIGO 1 6 GLUCOSIDASE//GLYCOSIDE HYDROLASE FAMILY 31

Go to start page